Bill > S2706

This bill, the DIVERSE Trials Act, aims to improve diversity in clinical trials and data collection for COVID-19 and future public health threats. It requires the Secretary of Health and Human Services to issue guidance on conducting decentralized clinical trials with meaningful demographic diversity, including strategies for engaging with diverse communities and recommendations for using digital health technologies. The bill also encourages clinical trial enrollment by racially and ethnically diverse populations by allowing drug or device manufacturers to provide digital health technologies to trial participants without violating certain laws. Additionally, the bill enhances COVID-19 data collection to address demographic data gaps and social determinants of health, and clarifies that certain remuneration related to participation in approved clinical trials does not constitute remuneration under the Federal Civil Money Penalties Law. Finally, the bill directs the National Academy of Medicine to study and propose a design for a national interoperable data platform to improve access to health and other relevant data during public health emergencies.

Health and Social Services

https://www.congress.gov/bill/117th-congress/senate-bill/2706/all-info